Biodistribution studies for cell therapy products: Current status and issues

Information on the biodistribution (BD) of cell therapy products (CTPs) is essential for prediction and assessment of their efficacy and toxicity profiles in non-clinical and clinical studies. To conduct BD studies, it is necessary to understand regulatory requirements, implementation status, and an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamiyama, Yoshiteru, Naritomi, Yoichi, Moriya, Yuu, Yamamoto, Syunsuke, Kitahashi, Tsukasa, Maekawa, Toshihiko, Yahata, Masahiro, Hanada, Takeshi, Uchiyama, Asako, Noumaru, Akari, Koga, Yoshiyuki, Higuchi, Tomoaki, Ito, Masahiko, Komatsu, Hiroyuki, Miyoshi, Sosuke, Kimura, Sadaaki, Umeda, Nobuhiro, Fujita, Eriko, Tanaka, Naoko, Sugita, Taku, Takayama, Satoru, Kurogi, Akihiko, Yasuda, Satoshi, Sato, Yoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282960/
https://www.ncbi.nlm.nih.gov/pubmed/34307798
http://dx.doi.org/10.1016/j.reth.2021.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282960/
https://www.ncbi.nlm.nih.gov/pubmed/34307798
http://dx.doi.org/10.1016/j.reth.2021.06.005

Ejemplares similares